Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay
Open accessAbstract
Background: There is growing interest in the use of multiplexed aptamer-based assays for large-scale proteomic studies. However, the analytic, short- and long-term variation of the measured proteins is largely uncharacterized. Methods: We quantified 4001 plasma protein analytes from 42 participants in the Atherosclerosis Risk in Communities (ARIC) Study in split samples and at multiple visits using a multiplexed modified aptamer assay. We calculated the CV, Spearman correlation, and intraclass correlation (ICC) between split samples and evaluated the short-term (4–9 weeks) and long-term (approximately 20 years) variability using paired t-tests with log-transformed protein concentrations and Bonferroni-corrected significance thresholds. We performed principal component (PC) analysis of protein analyte concentrations and evaluated their associations with age, sex, race, and estimated glomerular filtration rate (eGFR). Results: The mean baseline age was 57 years at the first visit, 43% of participants were male and 57% were white. Among 3693 protein analytes that passed quality control, half (n = 1846) had CVs < 5.0%, Spearman correlations > 0.89, and ICCs > 0.96 among the split samples. Over the short term, only 1 analyte had a statistically significant difference between the 2 time points, whereas, over approximately 20 years, 866 analytes (23.4%) had statistically significant differences (P < 1.4 × 10−5, 681 increased, 185 decreased). PC1 had high correlations with age (−0.73) and eGFR (0.60). PC2 had moderate correlation with male sex (0.18) and white race (0.31). Conclusions: Multiplexed modified aptamer technology can assay thousands of proteins with excellent precision. Our results support the potential for large-scale studies of the plasma proteome over the lifespan.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Proteins in plasma samples collected and processed by the MESA exam 1 protocol have been shown to be stable over time.
“Proteins in plasma samples collected in this manner have been shown to be stable over time44.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [44]
The Methods (Study population; page unavailable) describe plasma collected under the ARIC protocol, not the MESA exam 1 protocol. The Discussion (page unavailable) suggests protein analytes were stable over 4–9 weeks, but the Results report significant changes in 23.4% of analytes over approximately 20 years. The paper therefore supports short-term stability in a different sample set, not an unqualified claim of stability over time for MESA-collected samples. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754 · see citing works
Flagged first, then by citations
Research works printed but not linked: 27
- [1]Ellington AA, Kullo IJ, Bailey KR, Klee GG. Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem 2010; 56: 186– 93. 19959625 PMC2901849
- [2]Smith JG, Gerszten RE. Emerging affinity-based proteomic technologies for large-scale plasma profiling in cardiovascular disease. Circulation 2017; 135: 1651– 64. 28438806 PMC5555416
- [3]Taussig MJ, Schmidt R, Cook EA, Stoevesandt O. Development of proteome-wide binding reagents for research and diagnostics. Proteomics Clin Appl 2013; 7: 756– 66. 24178846
- [4]Ganz P, Heidecker B, Hveem K, Jonasson C, Kato S, Segal MR, Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA 2016; 315: 2532– 41. 27327800
- [5]Heier CR, Fiorillo AA, Chaisson E, Gordish-Dressman H, Hathout Y, Damsker JM, Identification of pathway-specific serum biomarkers of response to glucocorticoid and infliximab treatment in children with inflammatory bowel disease. Clin Transl Gastroenterol 2016; 7: e192. 27628422 PMC5288595
- [6]Ngo D, Sinha S, Shen D, Kuhn EW, Keyes MJ, Shi X, Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease. Circulation 2016; 134: 270– 85. 27444932 PMC4963294
- [7]Sattlecker M, Khondoker M, Proitsi P, Williams S, Soininen H, Kloszewska I, Longitudinal protein changes in blood plasma associated with the rate of cognitive decline in Alzheimer’s disease. J Alzheimers Dis 2016; 49: 1105– 14. 26599049
- [8]Benson MD, Yang Q, Ngo D, Zhu Y, Shen D, Farrell LA, Genetic architecture of the cardiovascular risk proteome. Circulation 2018; 137: 1158– 72. 29258991 PMC5849518
- [9]Candia J, Cheung F, Kotliarov Y, Fantoni G, Sellers B, Griesman T, Assessment of variability in the somascan assay. Sci Rep 2017; 7: 14248. 29079756 PMC5660188
- [10]Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem 2012; 58: 680– 9. 22311920 PMC5136473
- [11]The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687– 702. 2646917
- [12]Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604– 12. 19414839 PMC2763564
- [13]Parrinello CM, Grams ME, Couper D, Ballantyne CM, Hoogeveen RC, Eckfeldt JH, Recalibration of blood analytes over 25 years in the Atherosclerosis Risk in Communities study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem 2015; 61: 938– 47. 25952043 PMC4782184
- [14]Tworoger SS, Hankinson SE. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev 2006; 15: 1578– 81. 16985015
- [15]Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Hupo plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005; 5: 3262– 77. 16052621
- [19]Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996; 313: 106. 8688716 PMC2351517
- [20]Bonett D, Wright T. Sample size requirements for estimating Pearson, Kendall, and Spearman correlations. Psychometrika 2000; 65: 23– 8.
- [22]Pitman EJG. A note on normal correlation. Biometrika 1939; 31: 9– 12.
- [23]Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J, Stephen B. Consequences of natural perturbations in the human plasma proteome. Nature 2018; 558: 73– 79. 29875488 PMC6697541
- [24]Williams SA, Murthy AC, DeLisle RK, Hyde C, Malarstig A, Ostroff R, Improving assessment of drug safety through proteomics: early detection and mechanistic characterization of the unforeseen harmful effects of torcetrapib. Circulation 2018; 137: 999– 1010. 28974520 PMC5839936
- [25]De Groote MA, Higgins M, Hraha T, Wall K, Wilson ML, Sterling DG, Highly multiplexed proteomic analysis of quantiferon supernatants to identify biomarkers of latent tuberculosis infection. J Clin Microbiol 2017; 55: 391– 402. 27852671 PMC5277508
- [26]Christiansson L, Mustjoki S, Simonsson B, Olsson-Strömberg U, Loskog ASI, Mangsbo SM. The use of multiplex platforms for absolute and relative protein quantification of clinical material. EuPA Open Proteom 2014; 3: 37– 47.
- [27]Lim SY, Lee JH, Welsh SJ, Ahn SB, Breen E, Khan A, Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients. Biomark Res 2017; 5: 32. 29152306 PMC5681837
- [28]Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 2008; 102: 733– 7. 18773998
- [29]Pepys MB. C-reactive protein fifty years on. Lancet 1981; 1: 653– 7. 6110874
- [31]Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979; 16: 251– 70. 393891
- [32]Carone FA, Peterson DR, Oparil S, Pullman TN. Renal tubular transport and catabolism of proteins and peptides. Kidney Int 1979; 16: 271– 8. 529676
Cited by
Sorted by citations
Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
Walker, K. A., Chen, J., Zhang, J., Fornage, M., Yang, Y., Zhou, L., Grams, M. E., Tin, A., Daya, N., Hoogeveen, R. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00064-0 · Cited by 212 · see citing works
Self-citationComparison of Proteomic Assessment Methods in Multiple Cohort Studies
Raffield, L. M., Dang, H., Pratte, K. A., Jacobson, S., Gillenwater, L. A., Ampleford, E., Barjaktarevic, I., Basta, P., Clish, C. B., Comellas, A. P., et al. (2020) · PROTEOMICS · doi:10.1002/pmic.201900278 · Cited by 184 · see citing works
Johnson, A. A., Shokhirev, M. N., Wyss-Coray, T., & Lehallier, B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101070 · Cited by 166 · see citing works
Walker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf5681 · Cited by 148 · see citing works
Self-citationLindbohm, J. V., Mars, N., Walker, K. A., Singh‐Manoux, A., Livingston, G., Brunner, E. J., Sipilä, P. N., Saksela, K., Ferrie, J. E., Lovering, R. C., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12419 · Cited by 70 · see citing works
Cross-ancestry comparison of aptamer and antibody protein measures
Nicholas, J. C., Katz, D. H., Tahir, U. A., Debban, C. L., Aguet, F., Blackwell, T., Bowler, R. P., Broadaway, K. A., Chen, J., Clish, C. B., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67814-1 · Cited by 13 · see citing works
Self-citation
- Authors
- Tin, A., Yu, B., Ma, J., Masushita, K., Daya, N., Hoogeveen, R. C., Ballantyne, C. M., Couper, D., Rebholz, C. M., Grams, M. E., Alonso, A., Mosley, T., Heiss, G., Ganz, P., Selvin, E., Boerwinkle, E., & Coresh, J.
- Affiliations
- Johns Hopkins University (US)
- The University of Texas Health Science Center at Houston (US)
- Baylor College of Medicine (US)
- University of North Carolina at Chapel Hill (US)
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
- University of Mississippi Medical Center (US)
- San Francisco General Hospital (US)
- Corresponding author
- Tin, Adrienne
- ORCID
- Venue
- The Journal of Applied Laboratory Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-01
- Volume
- 4
- Issue
- 1
- Pages
- 30-39
- ISSN
- 2475-7241 (ISSN-L)
- 2576-9456
- PMC
- PMC6814271
- OpenAlex
- W2911979957
- Cited by
- 106
- References
- 1
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 20 · 2023: 16 · 2022: 23 · 2021: 10 · 2020: 5
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Applied Laboratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UNC Libraries
- Funders
- National Heart, Lung, and Blood Institute (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HSN268201100010C, HHSN268201100011C, HHSN268201100012C)
- NIH (U01 2U01HL096812, 2U01HL096814, 2U01HL096899, 2U01HL096902, 2U01HL096917)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK107782)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
- Keywords
- plasma proteome, assay reproducibility, estimated glomerular filtration rate
- MeSH terms
- Aged, Blood Proteins, Equipment Design, Female, Glomerular Filtration Rate, Humans, Male, Middle Aged, Prospective Studies, Reproducibility of Results, Proteomics, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review